Dr. Christopher Lipinski Melior Discovery Inc., USA

Dr. Christopher Lipinski learned his medicinal chemistry skills in a 32 year career at Pfizer in Groton, CT where he retired in 2002 at the most senior scientific position. He.is currently a Scientific Advisor to Melior Discovery a drug repurposing startup located in Exton, PA and carries out his medicinal... read morechemistry consulting through Christopher A. Lipinski, Ph.D., LLC located in Waterford CT. Chris served on the scientific advisory board for academic drug discovery efforts at the Center for Drug Discovery and Development at the K. U. Leuven, Belgium. He has been a conference committee member for the annual MIPTEC meeting in Basel Switzerland which is now the largest early drug discovery meeting in Europe. He is a member of the American Chemical Society (ACS) and the American Association of Pharmaceutical Sciences (AAPS). He is the author of the “rule of five” a widely used filter to select for acceptable drug oral absorption which now with over 6,000 citations is the most highly cited paper in medicinal chemistry drug discovery. Chris is a member of the ACS “Medicinal Chemistry Hall of Fame”. In 2006 he received an honorary law degree from the University of Dundee and won the Society of Biomolecular Sciences Achievement Award. In 2005 he won the ACS E. B. Hershberg Award for Important Discoveries in Medicinally Active Substances and in 2004 won the ACS Division of Medicinal Chemistry Award. An adjunct faculty member in Biochemistry at the University of Massachusetts Amherst, Chris has over 285 publications and invited presentations and 19 issued US patents. He can be contacted at clipinski@meliordiscovery.com.